308 related articles for article (PubMed ID: 25381821)
1. Wip1 phosphatase in breast cancer.
Emelyanov A; Bulavin DV
Oncogene; 2015 Aug; 34(34):4429-38. PubMed ID: 25381821
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of the wip1 gene abrogates the p38 MAPK/p53/Wip1 pathway and silences p16 expression in human breast cancers.
Yu E; Ahn YS; Jang SJ; Kim MJ; Yoon HS; Gong G; Choi J
Breast Cancer Res Treat; 2007 Mar; 101(3):269-78. PubMed ID: 16897432
[TBL] [Abstract][Full Text] [Related]
3. The type 2C phosphatase Wip1: an oncogenic regulator of tumor suppressor and DNA damage response pathways.
Lu X; Nguyen TA; Moon SH; Darlington Y; Sommer M; Donehower LA
Cancer Metastasis Rev; 2008 Jun; 27(2):123-35. PubMed ID: 18265945
[TBL] [Abstract][Full Text] [Related]
4. The role of the MKK6/p38 MAPK pathway in Wip1-dependent regulation of ErbB2-driven mammary gland tumorigenesis.
Demidov ON; Kek C; Shreeram S; Timofeev O; Fornace AJ; Appella E; Bulavin DV
Oncogene; 2007 Apr; 26(17):2502-6. PubMed ID: 17016428
[TBL] [Abstract][Full Text] [Related]
5. Wip1-deficient mice are resistant to common cancer genes.
Harrison M; Li J; Degenhardt Y; Hoey T; Powers S
Trends Mol Med; 2004 Aug; 10(8):359-61. PubMed ID: 15310454
[TBL] [Abstract][Full Text] [Related]
6. The estrogen receptor alpha pathway induces oncogenic Wip1 phosphatase gene expression.
Han HS; Yu E; Song JY; Park JY; Jang SJ; Choi J
Mol Cancer Res; 2009 May; 7(5):713-23. PubMed ID: 19435816
[TBL] [Abstract][Full Text] [Related]
7. p53-Independent expression of wild-type p53-induced phosphatase 1 (Wip1) in methylmethane sulfonate-treated cancer cell lines and human tumors.
Park JY; Song JY; Kim HM; Han HS; Seol HS; Jang SJ; Choi J
Int J Biochem Cell Biol; 2012 Jun; 44(6):896-904. PubMed ID: 22405851
[TBL] [Abstract][Full Text] [Related]
8. Wip1-dependent signaling pathways in health and diseases.
Zhu YH; Bulavin DV
Prog Mol Biol Transl Sci; 2012; 106():307-25. PubMed ID: 22340722
[TBL] [Abstract][Full Text] [Related]
9. Oncogenic Wip1 phosphatase is inhibited by miR-16 in the DNA damage signaling pathway.
Zhang X; Wan G; Mlotshwa S; Vance V; Berger FG; Chen H; Lu X
Cancer Res; 2010 Sep; 70(18):7176-86. PubMed ID: 20668064
[TBL] [Abstract][Full Text] [Related]
10. Regulation of the Wip1 phosphatase and its effects on the stress response.
Lowe J; Cha H; Lee MO; Mazur SJ; Appella E; Fornace AJ
Front Biosci (Landmark Ed); 2012 Jan; 17(4):1480-98. PubMed ID: 22201816
[TBL] [Abstract][Full Text] [Related]
11. WIP1 phosphatase as a potential therapeutic target in neuroblastoma.
Richter M; Dayaram T; Gilmartin AG; Ganji G; Pemmasani SK; Van Der Key H; Shohet JM; Donehower LA; Kumar R
PLoS One; 2015; 10(2):e0115635. PubMed ID: 25658463
[TBL] [Abstract][Full Text] [Related]
12. Wip1 controls global heterochromatin silencing via ATM/BRCA1-dependent DNA methylation.
Filipponi D; Muller J; Emelyanov A; Bulavin DV
Cancer Cell; 2013 Oct; 24(4):528-41. PubMed ID: 24135283
[TBL] [Abstract][Full Text] [Related]
13. Increased wild-type p53-induced phosphatase 1 (Wip1 or PPM1D) expression correlated with downregulation of checkpoint kinase 2 in human gastric carcinoma.
Fuku T; Semba S; Yutori H; Yokozaki H
Pathol Int; 2007 Sep; 57(9):566-71. PubMed ID: 17685927
[TBL] [Abstract][Full Text] [Related]
14. WIP1 phosphatase at the crossroads of cancer and aging.
Le Guezennec X; Bulavin DV
Trends Biochem Sci; 2010 Feb; 35(2):109-14. PubMed ID: 19879149
[TBL] [Abstract][Full Text] [Related]
15. Wip1 phosphatase: between p53 and MAPK kinases pathways.
Goloudina AR; Kochetkova EY; Pospelova TV; Demidov ON
Oncotarget; 2016 May; 7(21):31563-71. PubMed ID: 26883196
[TBL] [Abstract][Full Text] [Related]
16. Gain-of-function mutations of PPM1D/Wip1 impair the p53-dependent G1 checkpoint.
Kleiblova P; Shaltiel IA; Benada J; Ševčík J; Pecháčková S; Pohlreich P; Voest EE; Dundr P; Bartek J; Kleibl Z; Medema RH; Macurek L
J Cell Biol; 2013 May; 201(4):511-21. PubMed ID: 23649806
[TBL] [Abstract][Full Text] [Related]
17. Hormone-sensing cells require Wip1 for paracrine stimulation in normal and premalignant mammary epithelium.
Tarulli GA; De Silva D; Ho V; Kunasegaran K; Ghosh K; Tan BC; Bulavin DV; Pietersen AM
Breast Cancer Res; 2013 Jan; 15(1):R10. PubMed ID: 23369183
[TBL] [Abstract][Full Text] [Related]
18. Clinical Significance of the Wild Type p53-Induced Phosphatase 1 Expression in Invasive Breast Cancer.
Inoue Y; Yamashita N; Kitao H; Tanaka K; Saeki H; Oki E; Oda Y; Tokunaga E; Maehara Y
Clin Breast Cancer; 2018 Aug; 18(4):e643-e650. PubMed ID: 29275106
[TBL] [Abstract][Full Text] [Related]
19. Wip1: A candidate phosphatase for cancer diagnosis and treatment.
Oghabi Bakhshaiesh T; Majidzadeh-A K; Esmaeili R
DNA Repair (Amst); 2017 Jun; 54():63-66. PubMed ID: 28385459
[TBL] [Abstract][Full Text] [Related]
20. [Expression of proto-oncogene Wip1 in breast cancer and its clinical significance].
Yang DH; He JA; Li J; Ma WF; Hu XH; Xin SJ; Duan ZQ
Zhonghua Yi Xue Za Zhi; 2010 Mar; 90(8):519-22. PubMed ID: 20367961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
